中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [9]
上海药物研究所 [3]
自动化研究所 [1]
生态环境研究中心 [1]
近代物理研究所 [1]
采集方式
OAI收割 [15]
内容类型
期刊论文 [14]
学位论文 [1]
发表日期
2023 [2]
2022 [8]
2021 [3]
2020 [1]
2016 [1]
学科主题
筛选
浏览/检索结果:
共15条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Development of PI3Kγ selective inhibitors: the strategies and application
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 10
作者:
Gu, Dong-Yan
;
Zhang, Meng-Meng
;
Li, Jia
;
Zhou, Yu-Bo
;
Sheng, Rong
  |  
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2023/12/08
PI3K
PI3K gamma inhibitors
isoform selectivity
drug development
rational drug design
Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer
期刊论文
OAI收割
JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 12, 页码: 2315-2328
作者:
Luo, LingJie
;
Lin, Caiji
;
Wang, Pengfei
;
Cao, Danli
;
Lin, Yiru
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2023/10/17
Immune checkpoint inhibitor
Phytochemicals
Combination therapy
Immune-related adverse events
Predictive biomarker
Gut microbiota
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
期刊论文
OAI收割
CANCER MEDICINE, 2022
作者:
Hao, Yue
;
Lin, Gen
;
Xiang, Jing
;
Wang, Wenxian
;
Xu, Chunwei
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
efficacy
immune-related adverse events
immunotherapy
thymoma
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
期刊论文
OAI收割
THORACIC CANCER, 2022
作者:
Wang, Wenxian
;
Wang, Qian
;
Xu, Chunwei
;
Li, Ziming
;
Song, Zhengbo
  |  
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2022/12/23
checkpoint inhibitor pneumonitis
Chinese experts consensus
immune checkpoint inhibitor-related adverse effects
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial
期刊论文
OAI收割
BRITISH JOURNAL OF CANCER, 2022
作者:
Qin, Shukui
;
Li, Jin
;
Zhong, Haijun
;
Jin, Chuan
;
Chen, Lili
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/22
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
OAI收割
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression
期刊论文
OAI收割
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 6, 页码: 14
作者:
Huang, Jing
;
Wang, Xiaobo
;
Li, Bing
;
Shen, Shiyu
;
Wang, Ruina
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/08/16
Immunotherapy
Immune Evation
T-Lymphocytes
Translational Medical Research
Image classification of immune checkpoint inhibitor-related pneumonia in lung cancer patients
期刊论文
OAI收割
CLINICAL IMAGING, 2022, 卷号: 86
作者:
Sun, Xiaojun
;
Song, Zhengbo
;
Jiang, Hongyang
;
Ma, Yanqing
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
Immune checkpoint inhibitor (ICI)
Immune-related adverse events
Immune checkpoint inhibitor-related & nbsp
Lung cancer
Image classification
pneumonia (ICIP)
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
期刊论文
OAI收割
LANCET ONCOLOGY, 2022, 卷号: 23
作者:
Zhou, Qing
;
Chen, Ming
;
Jiang, Ou
;
Pan, Yi
;
Hu, Desheng
  |  
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2022/03/21
Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future
期刊论文
OAI收割
MOLECULAR IMAGING AND BIOLOGY, 2022, 页码: 16
作者:
Cheng, Zhongquan
;
Du, Yang
;
Yu, Leyi
;
Yuan, Zhu
;
Tian, Jie
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/03/17
Noninvasive imaging
Immune checkpoint inhibitor
Combined immunotherapy
Breast cancer